Colin P.N. Dinney, MD, provides some background on translational analyses from the BOND-003 and CORE-001 trials.

For those of us who have been in the field for decades, this cycle of exhilaration or despair is common and manageable, but recent months have raised even further uncertainty about how progress in ...